Changing the Practice of Medicine
Popular
- CME/CE
Precision Through the Continuum: Applying Biomarker-Guided Therapies in Ovarian Cancer
1.00 credit
Susana Campos, MD, MPH
Robert Coleman, MD, FACOG
Debra Richardson, MD
Neeraj Agarwal, MD, FASCO
Rana McKay, MD
Scott T. Tagawa, MD, MS
Mary-Ellen Taplin, MD
Alessandra Tedeschi, MD
Scott T. Tagawa, MD, MS
Mary-Ellen Taplin, MD
Scott T. Tagawa, MD, MS
Mary-Ellen Taplin, MD
- MinuteCE®
Winning the Battle Against Side Effects: Adverse Event Management in HSPC
1.00 program creditScott T. Tagawa, MD, MS
Mary-Ellen Taplin, MD
CME/CE
- CME/CE In-Person & Virtual Event
Today’s CLL/SLL Decisions, Tomorrow’s Options: Practical Strategies for the Community Clinic
September 11, 2026
Houston, Texas Neeraj Agarwal, MD, FASCO
Rana McKay, MD
Aditya Bardia, MD, MPH, FASCO
Erica L. Mayer, MD, MPH
- CME/CE Broadcast Replay
A Q-Challenge™ Replay: Advancing Precision Diagnosis and Treatment Strategies in Acromegaly
1.00 creditMaria Fleseriu, MD, FACE
Shlomo Melmed, MBChB
Elise M. Brett, MD, FACE
Clinical Practice
Scott T. Tagawa, MD, MS
Mary-Ellen Taplin, MD
Florence Odufalu, MD
Ugo Iroku, MD, MHS
Aditya Bardia, MD, MPH, FASCO
- Oncology and Hematology
DESTINY-Breast05 Findings Lead to New Indication for Trastuzumab Deruxtecan as Adjuvant Treatment for Residual Invasive Disease
Sara A. Hurvitz, MD, FACP
Programs
- MinuteCE®
IBD Care Reimagined: Personalized, Proactive, and Target-Driven Management
2.00 credits 13 episodesDavid T. Rubin, MD
Michael Dolinger, MD, MBA
Florence Odufalu, MD
Ugo Iroku, MD, MHS
Sharon Dudley-Brown, PhD, FNP-BC, FAAN, FAANP
Michael Dolinger, MD, MBA
David T. Rubin, MD
Michael Dolinger, MD, MBA
David T. Rubin, MD
Michael Dolinger, MD, MBA
David T. Rubin, MD
Florence Odufalu, MD
David T. Rubin, MD
Michael Dolinger, MD, MBA
David T. Rubin, MD